Roche is setting up a head-to-head phase 3 study in type 2 diabetes, putting its own drug directly against Mounjaro's active ingredient.
Recap by typeshit. Post by Bioinvestor24 on X.
The once-daily pill blocks the IL-23 receptor and helped people with moderate to severe ulcerative colitis respond more often than placebo, a new study reports.
Bikman welcomes a new result but argues the likely cause is tirzepatide bringing insulin down rather than the drug slowing aging itself. His view, not a study claim.
Marchione makes the case for pairing GLP-1s with drugs that target amylin, the hormone released after meals that signals fullness to the brain.
Regen says the placebo group saw a 9% drop, while people on retatrutide also lost 31 lb on average and saw systolic blood pressure fall 14 points.
A social clip on Eli Lilly's experimental drug retatrutide and its possible role in weight loss for people with type 2 diabetes. Thin on specifics.
Healio
Three months after the ADJUST-T1D trial ended, people who had been on semaglutide saw time in range drop 3.6 points, while those on placebo gained 1.5 points.
Loading…